KFDA approves additional indications of Zocor

Published: 2004-01-09 06:59:00
Updated: 2004-01-09 06:59:00
The Korea Food and Drug Administration announced it approved the additional indications of MSD Korea's lipid-lowering agent Zocor 40mg (simvastatin):

For patients with coronary heart disease (CHD) and high cholesterol, Zocor is indicated as an addition to diet to reduce the risk of death by re...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.